The road to IND isn’t always easy. Balancing speed, risk, and future needs is a challenge. Join Paul Jorjorian, Vice President and General Manager, Thermo Fisher Scientific, and learn how you can take your molecule from discovery to FiH trials without undue risk or excessive timelines. Plus, find out how you can meet short-term goals while preparing for future commercialization success. Register Now.
Life Sciences manufacturers that focus on streamlining the tendering and bidding process win more. Join our tender experts for a virtual session to learn strategies to optimize your bids, streamline processes, and improve collaboration and visibility across the tender lifecycle. You’ll also hear from Veronica Gil, Pricing & Tender Director, Baxter EMEA, on how her team leveraged technology to centralize processes and develop a winning tender strategy. Register Now.
Join this webinar to hear experts share how dissolution tools and PBPK modeling can help evaluate whether a molecule is suitable for controlled release applications and predict the effects of release rate on in vitro performance. In addition, the experts will cover all aspects of oral controlled release technologies and discuss current strategies to select the optimal technology to meet the intended release profile. Register Now.
Optimizing the manufacture and delivery of significant amounts of therapeutically potent cells, extend today’s frontiers in the field of cell therapy and regenerative medicine. Leaders in the pharma and biotech industry, health care sector and life science researchers will get insights about the latest advances in regenerative medicine, gene editing platforms, tackling the critical limitations in developing CRISPR therapeutics and more. Register Today.
Before COVID-19, the typical vaccine took more than five years to develop. Biopharma companies raced from virus discovery to phase 3 testing of their COVID-19 vaccines in under a year. Now the industry is asking an important question: Can we take what we learned from COVID-19 vaccine successes and use it to speed up the development of other vaccines? Register now.
As we head into ASCO weekend, cancer experts will highlight closely watched data sets to be unveiled at the meeting. This discussion will take a close look at oncology's hottest fields, including CAR-T and precision medicine, as panelists zero in on the conference's most highly anticipated studies, 2021's biggest research trends, and the data they're most looking forward to seeing. Register now.
The recently heightened awareness of racial discrimination coupled with COVID-19’s disproportionate toll on disadvantaged communities has spurred the need for change. Yet the lack of equity and representation of minority groups in clinical research has been an open concern for decades. Attendees will learn how to optimize patient diversity and inclusivity of clinical trials. Register Now.
Learn how human pluripotent stem cells (hPSCs) are being manufactured at scale for clinical applications under current Good Manufacturing Practices (cGMPs) from Dr. Dhruv Sareen, the Executive Director of the Cedars-Sinai Biomanufacturing Center. Register Now.
With patient care increasingly moving into outpatient facilities and even the home, auto-injectors are an increasingly viable option for enabling patients and their caregivers to self-administer therapies. However, there are a number of important considerations for pharmaceutical companies that are considering a move to auto-injector devices. Learn how product characteristics, formulation, and patient needs impact device selection and manufacturing processes – and how experienced partners can help. Download Now.
Learn how Philips and QIAGEN are using mRNA technology in OncoSignal tests to quantify functional activity of disease-relevant signal transduction pathways in any cell and tissue type. This webinar will explore applications for both preclinical disease modeling and clinical measurement of response to targeted therapies and immunotherapies. Register now.
FDA is opening up to data gathered outside the hermetically sealed clinical trial setting as regulators recognize the need for a more flexible framework for evaluating treatments. As a new approach that requires significant investment, RWE use requires the right talent and technology. Where to find those resources and how to deploy them are some of the questions companies face. We’ll address these questions and more with the help of current practitioners in the field. Register now.
Do you use ELISAs in your scientific research? If so, we want to hear from you. Please fill out this short survey to help us better understand your ELISA product needs both now and in the future. This survey will take 5-7 minutes to complete.
Interested in digitizing your R&D organization, but not sure where to start? Looking to move from a wealth of spreadsheets and outdated software systems into one centralized data repository? This webinar shows what a modern software system should look like for R&D and how that compares to how most companies operate today. Register Today!
An evolution of biopharmaceutical manufacturing processes needs to happen if the cell and gene therapy field is to keep pace with the speed of science. Download this whitepaper to learn more about breaking down the challenges posed by constrained capacity, how custom processes hold the industry back, why standardization is now possible and how it’s accelerating R&D, and putting standard processes and products into practice. Learn more.
UNITY Biotechnology partnered with Rho to execute a complex and fast-moving Osteoarthritis program with three concurrent clinical trials and database locks scheduled during the height of the COVID-19 pandemic. In this webinar, hear from both the Sponsor and CRO about the creative solutions they implemented and how they worked together to pivot quickly and meet critical study timelines in the midst of the pandemic. Register Now.
The field of oncology biomarker testing is growing rapidly. With so many new cancer treatments available requiring specific biomarkers for prescription, oncologists have plenty of new information to follow and many decisions to make when treating individual tumors. Register now.
Learn actionable and real-world recommendations from Honeywell’s experienced ICS/OT cybersecurity team, as they reveal how they’ve coached both sites and enterprises to establish a resilient ICS/OT cybersecurity program. Register Now!
Life science technology leaders will discuss how Apprentice.io’s pharma-compliant remote collaboration platform helped them steady supply chains, better manage operations, and increase speed to market during the pandemic. Hear about how the adoption of this platform helped their teams successfully navigate manufacturing challenges and ultimately deliver safer, more reliable drug products, treatments and therapies – from COVID to cancer. Register now.
Learn how Eli Lily put the power of text mining in the hands of primary (non-data-scientist) users through Linguamatics Web Portals. With the on-going information explosion, natural language processing (NLP)-based text mining has become important to gain meaning effectively from unstructured text. Register now.
Learn how Prognos Health and Datavant are transforming & improving the way life sciences can access an extensive network of integrated real world data sources to define an ideal patient cohort as well as key demographic, therapeutic & customer insights. Register now.
This survey examines the life sciences industry's progress in adopting patient-centric, decentralized clinical trials. The goal of this research is to understand the drivers, benefits, and barriers of a decentralized/hybrid trial model and its impact on clinical trial management. Please take 5-10 minutes to complete this survey—all qualified respondents will receive a $20 Amazon gift card, and can choose to receive a copy of the report when it's released.
This Fierce webinar will feature executives from leading biopharma companies and technology-development firms, who will describe the latest tools and techniques for improving biomarker discovery. They will discuss how they chose and deployed these technologies, provide examples of how they led to the discovery of novel biomarkers, and offer tips for selecting tools to aid in biomarker discovery and incorporating them into established R&D processes. Register Today!
As clinical treatment options become more patient-centric, digital therapeutics provide forward-looking biopharma players the opportunity to augment the value of their offerings to stakeholders. Learn about why, when, and how biopharma can cultivate these collaborations in our latest white paper! Download now.
This 77-page e-book explores 7 keys to success that any biopharma company needs to keep in mind as it enters Europe. This resource is helpful for companies that are considering a move into Europe, as well as those that are already present in Europe and working to maximize their opportunities there. Download now.
Investing in data standards plays a huge role in improving the quality of clinical studies. This free guide outlines how to involve the right stakeholders from the start, only collect what’s required to support study objectives, and determine when and how updates to standards should occur. Download now.
With increasing digital channels, pharmas are exploring new ways to reconcile the high volume of content creation with the need for more personal messaging. In this article, learn how one large pharma followed three key steps to embrace a modular approach and generate localized content faster. Download now.
In this webinar, IQVIA experts will focus on the medical technology (MedTech) environment, examining how and why RWE is imperative and should be leveraged early in planning stages. The speakers will explore ways in which RWE studies can provide meaningful support for research, marketing, clinical, regulatory decision making, and reimbursement requirements.
Learn which solutions manufacturers should consider from drug development through market maturity and when to start planning. Download the article.
The average clinical trial spends $40,000 per patient. Yet despite these high costs, most trials struggle to retain patients. When asked, patient experience issues are frequently mentioned by patients that leave trials early. By designing an intentional patient experience, sponsors can enhance patient compliance and retention, resulting in improved trial performance. This brief explains how.
Before 2020, web-based on-demand training was a novel concept used by only a few sponsors, and when the COVID-19 pandemic hit, web-based on-demand training became a necessity. Learn how combining on-demand training with web-based meetings has become the new best practice for clinical trials. Download now.
Biotechnology companies of all sizes face many challenges in the development of new cell and gene therapies. In this webinar, Mike O’Mara and Dr. Ian Gaudet will introduce the development and manufacturing approach used by Miltenyi Biotec and describe how a CDMO partner focused in process and analytical development can enable clinical readiness. Register Now.
The global biotech industry is booming with an estimated market size of more than $300 billion, and emerging biotechs are driving a large portion of innovation and development. To learn more, download the whitepaper.
At each step in the product life cycle, pharma, biotech and medtech companies need to engage with third parties to develop, manufacture and sell their drugs, diagnostics and devices. With lives at stake and multiple players pursuing opportunities, companies that close deals quickly have a competitive edge. Yet, each contract exposes a company to an array of major third-party risks, creating a need for systems that support both speed and quality. Download this playbook to learn more.
In 2020, consumers purchased over-the-counter (OTC) medicine heavily in March, but then shifted their consumption to vitamins and dietary supplements (VMS) for the remainder of the year. In this webinar, Catalent partnered with NielsenIQ to bring forward new insights that provide starting points for re-establishing growth via innovation in the OTC market. Save Your Spot - Register Now.
Evolving R&D priorities and resource constraints across the globe mean clinical trials are more complex than ever. At the same time, COVID-19 has highlighted the urgent need for a more resilient and robust supply chain. Biopharma companies are heeding the call to innovate, be agile, reduce waste and, most of all, achieve patient-centricity. Flexible solutions like demand-led supply and direct-to-patient distribution are helping sponsors address the growing list of challenges presented by today’s increasingly complex studies. Download to learn more.
These resources are brought to you by Cytiva. Learn more about Process Intensification on our website.
Biopharma companies need to monitor for and report adverse events to ensure patient safety and remain in compliance. But an increase in adverse event reports is exposing a lack of coordination across adverse event data sources and shortcomings of manual, human-centered systems. Learn more!
Managing drug product labeling is a challenge due to new data, required changes by regulations, poorly integrated legacy systems, fragmented manual processes, and other factors. A new, better approach to drug product labeling is needed. Download Now!
Attend this webinar to learn about the role neutralising antibody testing plays in antibody detection, response to mass vaccination, longevity of immunity to SARS-CoV-2, and examine performance characteristics data. Register now.
A one-stop hub for Cytiva resources to support process development and manufacturing of your novel molecule. Learn more.
COVID-19 has resulted in delayed care across specialties. Join us as we discuss returning to pre-pandemic clinical activity and strategies that biopharma organizations are using to engage HCPs. Register now.
As the field of protein therapeutics pushes into higher and higher concentration space, unique challenges that require creative solutions are becoming more evident. Drawing from a combined 40 years of biologics formulation experience, we have distilled key takeaways from high concentration development into this whitepaper. Download now.
With multiple COVID-19 vaccines approved and the rollout well underway, how can marketers best address misinformation, build trust, and win over the public? Get the latest insights into how you can use data, technology, and personalized messaging to build vaccine confidence and drive successful immunization efforts. Download the guide now.
New research explores the impact of the COVID-19 pandemic on clinical trial management, including the acceleration of decentralized clinical trials. This report provides invaluable insight into the key challenges and opportunities surrounding these changes in this new environment. Download the report.
Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM, a rare, life-threatening neuromuscular disease, affecting about 1 in 40-50,000 newborn males. The session will review how IPM.ia and Audentes collaborated to uncover the XLMTM patient population. Register now.
March Is Multiple Myeloma Month. In recognition of this important month, join us for a Precision Key Opinion Leader (KOL) Insights series webinar. You’ll hear from two leading investigators on the lessons learned, current trends, and insights relevant to the Multiple Myeloma (MM) US and EU research community. Dr. Paul Richardson and Dr. Maria-Victoria Mateos have collectively published >700 papers and both have been recognized for excellence in MM research. This is a rare opportunity to get a look into current MM treatment. Register Now.
The incorporation of patient-focused drug design principles early in the development cycle is critical to developing safe and effective treatments that address the specific needs of target patient populations in-terms of appropriateness, preference and usability. Download this Webinar to discover the current state of patient-focused dose design through clinical evidence, real-world case studies and patient preference-driven drug design solutions that can help develop better treatments and successful real-world outcomes.
Cell, gene-modified cell and gene therapies hold the promise to offer new hope and novel therapeutic avenues for individuals facing serious illnesses and medical conditions. But bringing these therapies successfully through the clinical trial process introduces a level of supply chain risk, complexity and specialized requirements which are not yet fully understood. This webinar focuses on taking a closer look at unique clinical supply challenges and unique needs associated with cell and gene therapies. Register Now.
Patient-focused drug design can be a key factor in real-world therapeutic outcomes and business success. But if successful treatments should be created with patients in mind, when is the optimal time to solicit this feedback? And, what are the best methods for interacting with patients during drug development? This eBook features insights from experts in the industry on patient-centric drug development challenges and strategies on advancing drug design and development effectively. Download Now.
In this webinar, industry experts discuss the recent advances, challenges and considerations in pediatric drug development. Real-life examples presented by the experts illustrate the impact of age-appropriate dose forms for pediatrics and highlight insights into the caregiver perspectives. Watch the webinar to learn about a case study on real-world medications and acceptability assessment. Download Now.
Scaling up research procedures into clinical-scale manufacturing of new cellular therapeutics presents a challenge for many academic facilities. Join Drs. Adrian Gee and David McKenna in this live webinar for a discussion about the issues to be addressed when translating your cell and gene therapy research to the clinic; from picking your team to finding an effective culture system and beyond. Register Now.
The FDA has hired more than 50 new reviewers in anticipation of receiving 200 applications per year from companies hoping to start clinical trials of gene and cell therapies and issuing 10 to 20 new approvals a year by 2025. This webinar will review the latest developments in the regulatory review process for gene and cell therapies, offering advice that companies can use to streamline their interactions with regulators, both in the U.S. and overseas. Register Now.
In this webinar, a panel of experts -- representing patient advocacy, cardiology, pharmaceutical, and health technology -- will discuss approaches for empowering individuals with heart conditions to act on best insights tailored to their specific situation (in a permissioned manner). Register Now.
Pharmaceutical companies face numerous hurdles during early development, from API manufacturing to drug product formulation to clinical supply logistics. Join Thermo Fisher Scientific experts to learn how a simplified supply chain may help increase efficiency and reduce risk as you move to your Phase I milestone. Register Now.
Different clinical trials have different supply needs and strategies. Download this free Q&A article to learn about stability strategy for clinical trials, the importance of supply chain communication, automated control systems and country-specific labeling protocols.
Planning on using a CRO to support your next clinical study? Here are the top 9 questions you should always ask to help your CRO or partner of choice better understand your clinical supply needs. Download this Infographic to learn more.
Accurate and timely delivery of clinical trial supplies helps to ensure that a study’s timeline stays on track. Sponsors often focus on upfront planning to ensure sites are prepared to reach clinical milestones but ignore the logistical challenges of reconciling and destroying clinical returns. Download this Article to learn about the top 3 clinical returns considerations for sponsors, how to anticipate requirements for clinical returns, and how country specific requirements can impact reverse logistics.
In this paper, Box will discuss how life sciences organizations can adapt to the new environment and propel therapies and medical devices through the value chain by rethinking content exchange. This paper will explain how cloud technologies accelerate the verification of documents and patient records at clinical trial sites, provide real-time access to regulated and non-regulated content, boost productivity and ensure GxP compliance to facilitate remote site monitoring. Download now.
The session is intended to help participants interact more effectively and constructively with their CRO partners and to ultimately save time, money & headaches in their development programs. Register Now!
The US FDA’s Breakthrough Therapy Designation, Regenerative Medicine Advanced Therapy Designation, Accelerated Approval Program, Priority Review, and Fast Track Designation can reduce your product’s development and approval timelines if pursued at the optimal time and implemented appropriately. Successfully navigate US FDA’s expedited programs for development of products for serious conditions: Understand the data expectations, planning and timing skills, and authoring strategies to optimize the chance of securing an expedited program designation. Register Now.
Join us to understand how organizations are moving into the next era of unparalleled data integration, seamless connectivity and intuitive design. Register Now.
Cell and gene therapies are placing the patient at the center of the supply chain in a vastly new way, with implications for production, financial operations, product ordering, logistics and patient access and support. With these high-value therapies gaining more acclaim and moving from academic treatment centers to community care, their therapeutic and commercial success will be more highly scrutinized. Register Now!
Join LabCorp and Nutanix for this one-hour webinar to learn how cloud infrastructure technology platform is transforming the business. You will learn how a design partnership between LabCorp and Nutanix can have a long-lasting positive impact in elevating the role of IT teams to become the strategic business partners for the organization.
This webinar will focus on how a pharmacist-led clinical trial model impacts the six key areas most relevant to clinical trials in today’s COVID and Decentralized Clinical Trial environment: regulations, recruiting, diversity, clinical outcomes, data integrity, and clinical supply chain. Register Now.
Are you looking for a higher-quality, faster-time to market manufacturing solution for your protein therapeutic? Webinar attendees will learn how AbSci and KBI’s partnership enables cell line development through bulk microbial GMP manufacturing in 6 months, using cutting edge cell line development and biomanufacturing technology. Register Now.
As modern life science R&D becomes more complex, variable, and fluid, organizations need informatics platforms that can keep up. Learn about the five essential capabilities of a life science R&D informatics platform in this whitepaper from Benchling. Download now.